Published in Hepatology on November 01, 1994
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol (1996) 1.31
HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol (2003) 1.08
Hepatitis C and liver transplantation. Gut (1999) 1.03
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut (1996) 0.96
HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J Gastroenterol (2001) 0.95
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation. Med Microbiol Immunol (2009) 0.87
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg (1998) 0.86
Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis. Am J Transplant (2008) 0.85
The impact of sirolimus on hepatitis C recurrence after liver transplantation. Can J Gastroenterol (2011) 0.82
Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci (1996) 0.81
Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents? World J Gastroenterol (2014) 0.81
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients. J Transplant (2012) 0.80
Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci (2004) 0.79
Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation. Arch Dis Child (1995) 0.76
Liver transplantation for hepatitis C virus related liver disease. Postgrad Med J (2005) 0.76
Orthotopic liver transplantation for hepatitis C infection: the best Christmas present? Ulster Med J (1998) 0.75
Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection? Gut (1999) 0.75
Outcome of orthotopic liver transplantation in patients with hepatitis C. Dig Dis Sci (2002) 0.75
Interferon-alpha therapy for chronic hepatitis C in special patient populations. Dig Dis Sci (1996) 0.75
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (1990) 4.10
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med (1995) 3.41
Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol (1992) 3.35
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80
Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A (1994) 2.69
Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63
Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun (1992) 2.55
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.49
Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology (2000) 2.46
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43
Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann Intern Med (2000) 2.43
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature (1983) 2.41
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Detection of hepatitis B virus sequences in serum by using in vitro enzymatic amplification. J Virol Methods (1988) 2.36
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16
Audit of pain after nasal surgery. Ann R Coll Surg Engl (1996) 2.10
Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04
Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet (1997) 2.01
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut (2000) 1.94
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93
Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol (1998) 1.91
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol (1985) 1.91
Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol (2001) 1.88
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet (1978) 1.85
Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84
Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology (2001) 1.84
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83
Hepatitis C virus biology. Cell Death Differ (2003) 1.83
Identification of cryptosporidium oocysts by monoclonal antibody. Lancet (1987) 1.79
Partial portacaval shunt: renaissance of an old concept. Surgery (1992) 1.79
Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion (1994) 1.78
Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology (1998) 1.74
The complete nucleotide sequence of the glnALG operon of Escherichia coli K12. Nucleic Acids Res (1987) 1.73
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg (2010) 1.72
Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis (2001) 1.71
Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center. Am J Transplant (2011) 1.70
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68
Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65
The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene (1999) 1.63
Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Gut (2008) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg (1988) 1.61
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology (1999) 1.60
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res (2001) 1.57
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut (1999) 1.55
Bronchobiliary fistulas in adults. Ann Surg (1988) 1.55
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res (2000) 1.53
Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod (1994) 1.53
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
Gallbladder cancer: the polyp-cancer sequence. Br J Surg (1990) 1.50
Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49
Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol (1990) 1.49
Hematobilia resulting from heterotopic stomach in the gallbladder neck. Surgery (1989) 1.48
Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol. Am Rev Respir Dis (1969) 1.47
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45